Procter & Gamble Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Procter & Gamble Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 18.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14
Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Procter & Gamble Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 11,691 | 2,140 | N/A | N/A | N/A |
| 12/31/2023 | 12,370 | 2,267 | 1,527 | 1,740 | N/A |
| 9/30/2023 | 12,370 | 2,314 | N/A | N/A | N/A |
| 6/30/2023 | 12,296 | 2,295 | 1,935 | 2,360 | N/A |
| 3/31/2023 | 12,243 | 2,408 | N/A | N/A | N/A |
| 12/31/2022 | 11,712 | 2,328 | 2,718 | 3,349 | N/A |
| 9/30/2022 | 11,392 | 2,008 | N/A | N/A | N/A |
| 6/30/2022 | 11,144 | 1,925 | 1,316 | 1,695 | N/A |
| 3/31/2022 | 11,039 | 1,853 | N/A | N/A | N/A |
| 12/31/2021 | 10,552 | 1,499 | 816 | 1,157 | N/A |
| 9/30/2021 | 10,176 | 1,729 | N/A | N/A | N/A |
| 6/30/2021 | 10,087 | 1,768 | 1,947 | 2,473 | N/A |
| 3/31/2021 | 9,219 | 1,884 | N/A | N/A | N/A |
| 12/31/2020 | 9,308 | 2,191 | N/A | N/A | N/A |
| 9/30/2020 | 9,274 | 1,894 | N/A | N/A | N/A |
| 6/30/2020 | 8,886 | 1,659 | 1,414 | 1,569 | N/A |
| 3/31/2020 | 9,237 | 1,645 | N/A | N/A | N/A |
| 12/31/2019 | 9,266 | 1,588 | 1,512 | 1,619 | N/A |
| 9/30/2019 | 8,942 | 1,340 | N/A | N/A | N/A |
| 6/30/2019 | 8,952 | 1,394 | N/A | N/A | N/A |
| 3/31/2019 | 8,819 | 1,281 | N/A | N/A | N/A |
| 12/31/2018 | 8,490 | 1,017 | -1,571 | -1,304 | N/A |
| 9/30/2018 | 12,290 | 1,349 | N/A | N/A | N/A |
| 6/30/2018 | 12,087 | 1,140 | N/A | N/A | N/A |
| 3/31/2018 | 11,762 | 1,018 | N/A | N/A | N/A |
| 12/31/2017 | 6,981 | 610 | N/A | 537 | N/A |
| 9/30/2017 | 10,523 | 828 | N/A | N/A | N/A |
| 6/30/2017 | 10,088 | 797 | N/A | N/A | N/A |
| 3/31/2017 | 10,177 | 823 | N/A | N/A | N/A |
| 12/31/2016 | 9,926 | 791 | N/A | 1,070 | N/A |
| 9/30/2016 | 9,810 | 723 | N/A | N/A | N/A |
| 6/30/2016 | 9,681 | 572 | N/A | N/A | N/A |
| 3/31/2016 | 9,589 | 562 | N/A | N/A | N/A |
| 12/31/2015 | 9,383 | 536 | N/A | 835 | N/A |
| 9/30/2015 | 9,148 | 401 | N/A | N/A | N/A |
| 6/30/2015 | 8,798 | 451 | N/A | N/A | N/A |
| 3/31/2015 | 8,712 | 493 | N/A | N/A | N/A |
| 12/31/2014 | 8,662 | 432 | N/A | 50 | N/A |
| 9/30/2014 | 8,544 | 516 | N/A | N/A | N/A |
| 6/30/2014 | 8,409 | 498 | N/A | N/A | N/A |
| 3/31/2014 | 8,082 | 455 | N/A | N/A | N/A |
| 12/31/2013 | 7,965 | 559 | N/A | 5 | N/A |
| 9/30/2013 | 7,599 | 665 | N/A | N/A | N/A |
| 6/30/2013 | 7,404 | 765 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PGHL's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if PGHL's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if PGHL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PGHL's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if PGHL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PGHL's Return on Equity is forecast to be high in 3 years time